Cargando…
Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
PURPOSE: The intermediate stage of hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] B) comprises a highly heterogeneous population, and the treatment strategy is still controversial. Because of the heterogeneity, a subclassification of intermediate-stage HCCs was put forward by B...
Autores principales: | Zhaohui, Zhang, Shunli, Shen, Bin, Chen, Shaoqiang, Li, Yunpeng, Hua, Ming, Kuang, Lijian, Liang, Gang, Peng Bao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333972/ https://www.ncbi.nlm.nih.gov/pubmed/29510616 http://dx.doi.org/10.4143/crt.2018.038 |
Ejemplares similares
-
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016) -
Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma
por: Liu, Wei, et al.
Publicado: (2016) -
A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage
por: Ninomiya, Masashi, et al.
Publicado: (2023) -
The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma
por: Ke, Lixin, et al.
Publicado: (2020) -
Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System
por: Wee, Ian J Y, et al.
Publicado: (2022)